13F Holdings
中文EN

OM Outset Medical, Inc.

Electromedical & Electrotherapeutic Apparatus · Nasdaq · SEC CIK 1484612 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY1.6%
TTM net income YoY19.0%
TTM EPS YoY67.5%
Revenue 3-yr CAGR-2.6%
Net income 3-yr CAGR—

Margins

Gross margin42.0%
Operating margin-51.2%
Net margin-58.3%
FCF margin-35.2%
EBITDA margin-48.8%

Returns

ROE-63.0%
ROA-28.0%
ROIC (approx.)-28.3%
Asset turnover0.48x

Leverage & solvency

Liabilities / assets63.8%
Debt / equity1.18x
Current ratio4.86x
Interest coverage-4.54x

Cash quality & payout

Operating cash flow / net income0.60x
Accruals ratio-11.3%
Payout ratio—
Capex / revenue0.4%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$119.48M$113.69M$130.38M$115.38M$102.60M
Cost of revenue$72.72M$75.12M$101.38M$97.54M$94.99M
Gross profit$46.75M$38.56M$29.00M$17.83M$7.61M
R&D expense$21.23M$38.40M$57.31M$48.85M$36.74M
SG&A expense$37.86M$43.50M$45.23M$40.52M$36.32M
Operating income-$66.71M-$113.38M-$169.77M-$161.02M-$130.52M
Interest expense$13.95M$23.87M$12.68M$3.57M$1.72M
Pretax income-$80.94M-$127.48M-$172.27M-$162.66M-$131.74M
Income tax$718,000$491,000$523,000$295,000$199,000
Net income-$81.65M-$127.98M-$172.80M-$162.96M-$131.94M
EBITDA-$62.37M-$107.65M-$163.96M-$155.85M-$125.36M
EPS (basic)-5.37-36.96-52.28-3.38-2.89
EPS (diluted)-5.37-36.96-52.28-3.38-2.89
Weighted avg. shares (diluted)15,2113,4633,30548,16145,589
Balance sheet
Cash & equivalents$35.01M$124.01M$68.51M$73.22M$182.35M
Short-term investments$133.94M$34.67M$134.81M$214.28M$157.14M
Receivables$28.33M$35.62M$32.98M$28.07M$25.60M
Inventory$47.61M$59.39M$49.22M$51.48M$39.19M
Current assets$250.88M$258.22M$291.22M$373.64M$409.80M
PP&E, net$4.67M$8.13M$13.27M$15.88M$12.96M
Total assets$264.50M$275.80M$313.80M$400.12M$463.46M
Current liabilities$37.63M$45.38M$55.32M$51.95M$51.70M
Short-term debt———$4.75M$0
Long-term debt$96.24M$197.38M$130.11M$96.34M$29.76M
Total debt$96.24M$197.38M$130.11M$101.09M$29.76M
Total liabilities$137.54M$248.98M$190.91M$154.12M$89.38M
Shareholders' equity$126.95M$26.82M$122.89M$245.99M$374.08M
Net debt$61.23M$73.36M$61.60M$27.86M-$152.59M
Shares outstanding18.17M3.53M50.32M48.47M47.24M
Cash flow statement
Operating cash flow-$46.33M-$116.30M-$131.37M-$145.73M-$130.26M
Capital expenditure$798,000$912,000$3.44M$8.32M$3.11M
Free cash flow-$47.12M-$117.22M-$134.81M-$154.05M-$133.37M
Investing cash flow-$97.68M$103.94M$83.03M-$66.30M-$142.51M
Financing cash flow$55.50M$67.87M$43.65M$72.90M$160.15M
Depreciation & amortization$4.34M$5.73M$5.81M$5.17M$5.16M
Stock-based compensation$15.62M$29.36M$38.63M$27.20M$17.45M

Free plan shows the latest 5 periods; Pro shows all 8 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.